Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Research

• Publication date

  2017-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-17-0925PMID 28830860PMCID PMC5645248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reprogramming progeria fibroblasts re‐establishes a normal epigenetic landscape

  2017cited by this paper
• Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation

  2017cited by this paper
• Tuberous sclerosis complex

  2016cited by this paper
• Robust generation and expansion of skeletal muscle progenitors and myocytes from human pluripotent stem cells.

  2016cited by this paper
• Pluripotent stem cells in disease modelling and drug discovery

  2016cited by this paper
• Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex

  2016cited by this paper
• mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis.

  2016cited by this paper
• Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation

  2016cited by this paper
• Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.

  2016cited by this paper
• Autophagy and mTORC1 regulate the stochastic phase of somatic cell reprogramming

  2015cited by this paper
• Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis

  2015cited by this paper
• Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.

  2015cited by this paper
• The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis

  2014cited by this paper
• Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells

  2014cited by this paper
• Sox17-mediated XEN cell conversion identifies dynamic networks controlling cell-fate decisions in embryo-derived stem cells.

  2014cited by this paper
• In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor

  2014cited by this paper
• Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.

  2014cited by this paper
• Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells.

  2013cited by this paper
• Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.

  2013cited by this paper
• Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models

  2013cited by this paper
• Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide

  2013cited by this paper
• Detection of mycoplasma contaminations.

  2013cited by this paper
• Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis.

  2013cited by this paper
• Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis.

  2013cited by this paper
• Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency.

  2013cited by this paper
• Modeling and Rescue of the Vascular Phenotype of Williams‐Beuren Syndrome in Patient Induced Pluripotent Stem Cells

  2013cited by this paper
• Lymphangioleiomyomatosis - a wolf in sheep's clothing.

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• A more efficient method to generate integration-free human iPS cells

  2011cited by this paper
• Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent

  2011cited by this paper
• Chemically defined conditions for human iPS cell derivation and culture

  2011cited by this paper
• Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.

  2010cited by this paper
• Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

  2010cited by this paper
• Animal Models of Lymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Complex (TSC)

  2010cited by this paper
• Lymphangioleiomyomatosis and TSC2-/- Cells

  2010cited by this paper
• Epigenetic memory in induced pluripotent stem cells

  2010cited by this paper
• EOS lentiviral vector selection system for human induced pluripotent stem cells

  2009cited by this paper
• Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

  2007cited by this paper
• A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells.

  2007cited by this paper
• Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice.

  2006cited by this paper
• Detection of mycoplasma contaminations.

  2005cited by this paper
• Combined Smooth Muscle and Melanocytic Differentiation in Lymphangioleiomyomatosis

  2004cited by this paper
• Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.

  2004cited by this paper
• The LAM cell: what is it, where does it come from, and why does it grow?

  2004cited by this paper
• TSC2 mediates cellular energy response to control cell growth and survival.

  2003cited by this paper
• The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms.

  2001cited by this paper
• Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.

  2000cited by this paper
• Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.

  1999cited by this paper
• HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis.

  1994cited by this paper
• Pulmonary lymphangiomyomatosis. A review.

  1975cited by this paper

• Prognostic Significance of LGALS3BP in Triple‐Negative Breast Cancer: Implications for Immune Infiltration and Therapeutic Response

  2025cites this paper
• Enhanced Gαq Signaling in TSC2-deficient Cells Is Required for Their Neoplastic Behavior.

  2024cites this paper
• Tissue‐Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition

  2023cites this paper
• Emerging Methods in Modeling Brain Development and Disease with Human Pluripotent Stem Cells.

  2022cites this paper
• Progress and possibilities for patient-derived iPSCs and genetically engineered stem cells in cancer modeling and targeted therapies

  2022cites this paper
• Lymphangioleiomyomatosis, a metastatic lung disease.

  2022cites this paper
• Renal neoplasms in tuberous sclerosis mice are neurocristopathies

  2021cites this paper
• Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis

  2021cites this paper
• Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue

  2021cites this paper
• Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function

  2021cites this paper
• Sirolimus Suppresses Phosphorylation of Cofilin and Reduces Interstitial Septal Thickness in Sporadic Lymphangioleiomyomatosis

  2021cites this paper
• Organelle Cooperation in Stem Cell Fate: Lysosomes as Emerging Regulators of Cell Identity

  2020cites this paper
• The Role of iPSC Modeling Toward Projection of Autophagy Pathway in Disease Pathogenesis: Leader or Follower

  2020cites this paper
• Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex

  2020influential citation
• Adoptive T Cell Transfer to Treat Lymphangioleiomyomatosis.

  2020cites this paper
• Human Pluripotent Stem Cell Modeling of Tuberous Sclerosis Complex Reveals Lineage-Specific Therapeutic Vulnerabilities

  2020cites this paper
• FOXO transcription factor family in cancer and metastasis

  2020cites this paper
• Application of Induced Pluripotent Stem Cells in Epilepsy.

  2020cites this paper
• Stem cell models identify lineage-specific catabolic signaling, neoplastic mechanisms and therapeutic vulnerabilities in tuberous sclerosis

  2019cites this paper
• A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis

  2019cites this paper
• Circulating Lymphangioleiomyomatosis Tumor Cells With Loss of Heterozygosity in the TSC2 Gene Show Increased Aldehyde Dehydrogenase Activity.

  2019cites this paper
• Somatic Cell Epigenetic Reprogramming: Molecular Mechanisms and Therapeutic Potential

  2019cites this paper
• The discovery of novel mechanisms for lymphangioleiomyomatosis pathogenesis through GWAS: a rarity in rare respiratory disorders

  2019cites this paper
• 1 TSC 2-deficiency potentiates a catabolic signaling switch that differentiates neural and neural crest lineage development and progressive disease manifestations

  2019cites this paper
• Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

  2018cites this paper
• Rationally Designed 3D Hydrogels Model Invasive Lung Diseases Enabling High‐Content Drug Screening

  2018cites this paper
• Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

  2018cites this paper
• Emerging biomarkers of lymphangioleiomyomatosis

  2018cites this paper
• Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells

  2018influential citation
• The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models

  2018cites this paper
• Reprogramming patient-derived tumor cells generates model cell lines for tuberous sclerosis-associated lymphangioleiomyomatosis

  2017cites this paper